| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | — | +32.7% |
| Cost of Revenue | $281K | — | +47.1% |
| Gross Profit | $1.2M | — | +29.6% |
| R&D Expense | $19K | — | +216.7% |
| SG&A Expense | $2.0M | — | -5.1% |
| Operating Income | -$878K | — | +29.9% |
| Interest Expense | $10K | — | -54.5% |
| Net Income | -$852K | — | +31.5% |
| EPS (Basic) | -$0.12 | — | +40.0% |
| EPS (Diluted) | -$0.12 | — | +40.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $63K | +80.0% | +950.0% |
| Inventory | $502K | +18.7% | +104.9% |
| Current Assets | $2.0M | +109.5% | +84.1% |
| Total Assets | $2.6M | +68.4% | +65.9% |
| Current Liabilities | $2.9M | +0.5% | -13.8% |
| Total Liabilities | $3.0M | +0.1% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$471K | — | -824.6% |
| Capital Expenditures | $14K | — | — |
| Investing Cash Flow | -$14K | — | — |
| Financing Cash Flow | $1.3M | — | — |
| Free Cash Flow | -$485K | — | — |
| -12.0% |
| Stockholders' Equity | -$383K | +73.1% | +78.8% |